Lauren Rusckowski Duprey

Insider profile

Lauren Rusckowski Duprey's trades of Takeda Pharmaceutical Co Ltd's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
456.17
Quantity 72,868 -24.6%
Value US$1,726,405
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-09-15 2026-09-14 S Sale
72,868 -24.6%
456.17
US$1,726,405
72,868 -24.6% 456.17 US$1,726,405
2026-09-10 2026-09-10 PrS Proposed sale
91,377
250.66
US$4,551,337
91,377 250.66 US$4,551,337
2026-08-12 2026-08-10 S Sale
96,545 -7.8%
439.30
US$4,634,073
96,545 -7.8% 439.30 US$4,634,073
2026-07-13 2026-07-13 PrS Proposed sale
51,579
16.75
US$863,947
51,579 16.75 US$863,947
2025-12-09 2025-12-09 PrS Proposed sale
29,619
14.22
US$421,182
29,619 14.22 US$421,182
2025-07-09 2025-07-09 PrS Proposed sale
40,919
15.42
US$630,971
40,919 15.42 US$630,971
2024-07-10 2024-07-11 PrS Proposed sale
27,603
13.18
US$363,808
27,603 13.18 US$363,808
2023-07-10 2023-07-11 PrS Proposed sale
10,732
15.48
US$166,131
10,732 15.48 US$166,131